Cytocom (CBLI) – Major News
-
Cytocom (CBLI) Reports Q2 Loss of $0.04
-
Cytocom and Cleveland BioLabs (CBLI) Announce All-Stock Merger
-
Cleveland Biolabs (CBLI) Reports Q2 Loss of $0.50/Share
-
Cleveland Biolabs (CBLI) Posts Narrower Q2 Loss
-
Cleveland Biolabs (CBLI) Reports Q1 Loss of $0.06/Share
-
Cleveland Biolabs (CBLI) Reports Q3 Loss of $0.31
-
Cleveland Biolabs (CBLI) Reports Q2 Loss of $1.12
-
Cleveland Biolabs (CBLI) Reports Q1 Loss of $1.14
-
Cleveland Biolabs, Inc. (CBLI) Posts Q4 Loss of 1c/Share
-
Cleveland BioLabs (CBLI) Reports Termination of BARDA Registrations
-
Cleveland Biolabs, Inc. (CBLI) Post Smaller Than Expected Q3 Loss
-
Cleveland Biolabs, Inc. (CBLI) Posts Q2 Loss of 7c/Share
-
Cleveland Biolabs, Inc. (CBLI) Posts Q1 Loss of 22c/Share
-
Cleveland Biolabs, Inc. (CBLI) Swings to Q4 Profit
-
Cleveland Biolabs, Inc. (CBLI) Posts Wider than Expected Q2 Loss
-
Cleveland Biolabs, Inc. (CBLI) Posts In-Line Q1 Loss of 15c/Share
-
Cleveland Biolabs, Inc. (CBLI) Misses Q4 EPS by 2c
-
Cleveland BioLabs (CBLI) Treatment Not Accepted for DoD Award
Back to CBLI Stock Lookup